Cilcare Email Format
Biotechnology ResearchOccitanie, France51-200 Employees
CILCARE is a biotechnology research company focused on auditory science, aiming to advance early diagnosis and targeted treatment by treating hearing as a window into overall health. Its work spans external innovation for developing therapies to prevent and treat hearing-related conditions, therapeutic programs with proprietary drug candidates and co-developed initiatives, and auditory analytics designed to use patient hearing measurements to characterize various impairments and related pathologies with precision. The company targets healthcare and life-sciences partners seeking solutions for inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss, tinnitus, and related chronic conditions, positioning itself at the intersection of neuroscience, audiology, and preventive medicine. Based in Montpellier, France, CILCARE operates across multiple programs and collaborations, including clinical effort focused on a lead candidate advancing toward trials in partnership with Massachusetts General Hospital. Recent activities include initiatives to support foreign biotech entry into the U.S. market and participation in industry conferences and meetings that highlight its ongoing expansion and research in hearing-related health care.